News

The reserarchers found that a weekly dose of semaglutide was effective at treating Metabolic Dysfunction-Associated ...
Data across obesity, cardiovascular disease, MASH, type 2 diabetes, as well as advances in obesity-related care to be ...
Galmed Pharmaceuticals Ltd. ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for cardiometabolic diseases and GI oncological therapeutics, announced today that the first set of ...
The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...
I t’s hard to overstate just how revolutionary the development of medications like Ozempic and Wegovy has been for managing ...
A major international study has found that semaglutide, a drug already used to treat type 2 diabetes and obesity, can ...